Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Holly Maples

Concepts (98)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vancomycin
8
2023
91
2.150
Why?
Anti-Bacterial Agents
14
2025
832
1.520
Why?
Methicillin-Resistant Staphylococcus aureus
7
2023
83
1.390
Why?
Staphylococcal Infections
7
2023
271
1.060
Why?
Area Under Curve
5
2021
185
0.370
Why?
Microbial Sensitivity Tests
4
2021
276
0.330
Why?
Cystic Fibrosis
2
2022
155
0.280
Why?
Pediatrics
2
2013
307
0.270
Why?
Triazoles
2
2005
114
0.240
Why?
Malaria
1
2006
37
0.240
Why?
Pyrimidines
2
2005
206
0.230
Why?
Drug Monitoring
3
2020
81
0.210
Why?
Antifungal Agents
2
2005
350
0.210
Why?
Referral and Consultation
1
2006
299
0.210
Why?
Child
11
2024
7384
0.200
Why?
Patient-Centered Care
1
2025
141
0.200
Why?
Trichosporon
1
2003
13
0.200
Why?
Arthritis, Infectious
1
2024
45
0.200
Why?
Humans
21
2025
53246
0.190
Why?
Famotidine
1
2003
11
0.190
Why?
Histamine H2 Antagonists
1
2003
28
0.190
Why?
Medicaid
1
2025
294
0.190
Why?
Mycoses
1
2003
152
0.180
Why?
Bacteremia
1
2023
87
0.180
Why?
Osteomyelitis
1
2024
134
0.180
Why?
Practice Guidelines as Topic
3
2020
502
0.180
Why?
Kidney Failure, Chronic
1
2003
210
0.160
Why?
Consensus
1
2021
206
0.160
Why?
Communicable Diseases
1
2020
54
0.150
Why?
United States
7
2025
5413
0.130
Why?
Hospitals, Pediatric
1
2018
243
0.130
Why?
Respiratory System
1
2015
28
0.120
Why?
Tracheostomy
1
2015
76
0.110
Why?
Respiratory Tract Infections
1
2015
82
0.110
Why?
Inappropriate Prescribing
1
2013
27
0.100
Why?
Drug Resistance, Bacterial
1
2013
80
0.100
Why?
Infant
5
2015
3808
0.080
Why?
Pharmacists
2
2020
155
0.070
Why?
Plasmodium
1
2006
5
0.060
Why?
Specialization
1
2006
48
0.060
Why?
Geography
1
2006
65
0.060
Why?
Antimalarials
1
2006
34
0.060
Why?
Medicine
1
2006
51
0.060
Why?
Child, Preschool
4
2015
4164
0.060
Why?
Amphotericin B
1
2005
105
0.050
Why?
Azithromycin
1
2005
25
0.050
Why?
Antiretroviral Therapy, Highly Active
1
2004
32
0.050
Why?
Candidiasis
1
2005
114
0.050
Why?
Treatment Refusal
1
2004
35
0.050
Why?
HIV-1
1
2004
60
0.050
Why?
Mucorales
1
2024
12
0.050
Why?
Mucormycosis
1
2024
28
0.050
Why?
Micronesia
1
2024
111
0.050
Why?
Fatal Outcome
1
2003
193
0.050
Why?
Neutropenia
1
2003
113
0.050
Why?
Tissue Distribution
1
2003
174
0.050
Why?
Methicillin
1
2020
10
0.040
Why?
Adolescent
3
2015
6912
0.040
Why?
Staphylococcus aureus
1
2023
313
0.040
Why?
Societies, Pharmaceutical
1
2020
15
0.040
Why?
HIV Infections
1
2004
402
0.040
Why?
Aging
1
2005
715
0.040
Why?
Arkansas
1
2025
2068
0.040
Why?
Lung
1
2022
481
0.040
Why?
Societies, Medical
1
2020
207
0.040
Why?
Adult
1
2015
14541
0.040
Why?
Medical Staff, Hospital
1
2018
16
0.030
Why?
Bacteriological Techniques
1
2018
38
0.030
Why?
Developed Countries
1
2018
17
0.030
Why?
Inflammation
1
2022
653
0.030
Why?
Bacterial Infections
1
2018
96
0.030
Why?
Pseudomonas Infections
1
2015
54
0.030
Why?
Pseudomonas aeruginosa
1
2015
78
0.030
Why?
Acute Kidney Injury
1
2020
400
0.030
Why?
Infusions, Intravenous
2
2005
211
0.030
Why?
Infant, Newborn
2
2015
2913
0.030
Why?
Government Regulation
1
2013
15
0.020
Why?
Infection Control
1
2013
45
0.020
Why?
Patient Safety
1
2013
103
0.020
Why?
Program Development
1
2013
165
0.020
Why?
Male
3
2024
27444
0.020
Why?
Health Policy
1
2013
165
0.020
Why?
Female
3
2024
28792
0.020
Why?
Program Evaluation
1
2013
359
0.020
Why?
Animals
1
2006
13528
0.020
Why?
Attitude of Health Personnel
1
2013
371
0.020
Why?
Retrospective Studies
2
2015
6821
0.020
Why?
Directly Observed Therapy
1
2004
5
0.010
Why?
Drug Resistance, Viral
1
2004
7
0.010
Why?
Foster Home Care
1
2004
15
0.010
Why?
Treatment Failure
1
2004
119
0.010
Why?
Viral Load
1
2004
83
0.010
Why?
RNA, Viral
1
2004
123
0.010
Why?
Chromatography, High Pressure Liquid
1
2005
333
0.010
Why?
Home Care Services
1
2004
72
0.010
Why?
Mass Spectrometry
1
2005
294
0.010
Why?
Child Abuse
1
2004
145
0.010
Why?
Infant, Premature
1
2005
331
0.010
Why?
Maples's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description